Kaitlin Kestenberg

Kaitlin Kestenberg

Chief Operating Officer & Senior Vice President, ComplianceatAdma Biologics· In proxies 2022–2025

Pay in FY2025+4% from the year before · Adma Biologics stock +6.4% the same year

Kaitlin Kestenberg was paid $3.5M in FY2025 (Dec), up 4%. Adma Biologics stock rose 6.4% that year.

Pay$100 in the stock at the end of FY21 → $1.3K
Pay is from the Summary Compensation Table of each Adma Biologics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Adma BiologicsPublic company · 4 yr
    • Chief Operating Officer & Senior Vice President, Compliance2022 – Present · 4 yrStock in role +802%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?